This study, thus, implies that the stability of the pro-atherogenic endothelial cell receptor ETAR and ETBR is directly controlled by CSN5, but in vivo evidence shows that this may play a role in atherosclerosis and mechanistic insight shows how ETR engagement of CSN5 leads to receptor degradation. The gene discussed is COPS5; the disease is atherosclerosis.